Health After Covid-19 in Tyrol

Health After COVID-19 in the European Region Tyrol - South Tyrol

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04661462

Enrollment

1000

Registered

2020-12-10

Start date

2020-09-30

Completion date

2021-12-31

Last updated

2020-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

long term sequelae

Brief summary

The aim of the regional online questionnaire is to better understand the pattern of acute infection and the time of recovery of various symptoms.

Detailed description

The ongoing COVID-19 pandemic considerably increases the demand for healthcare and raises concerns on longterm disease outcome. Accordingly, to increase the knowledge on recovery from symptoms of acute infection and longterm health effects, a regional COVID-19 online survey on the health-status after infection will be performed. This cross-sectional anonymous online survey is initiated and conducted by an interdisciplinary study team of the Medical University of Innsbruck, Austria. For each participant, demographic characteristics (e.g. age, gender, district affiliation, profession), medical history (presence of comorbidities, medication), diagnosis of COVID-19, symptoms and their duration, treatments and special conditions will be collected. The aim of the survey is to better understand the pattern of acute infection and the time of recovery of various symptoms. The anonymous online survey is open to individuals after COVID-19 infection (proven by SARS-Cov-2 positive PCR or antibody test) over the age of 16 and living in Tyrol (Western-Austria). The survey takes around 30 minutes to complete.

Interventions

OTHERonline survey

We invite volunteers after COVID-19 to participate in an online survey.

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

16 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* status post COVID-19 infection, defined by a positive SARS-Cov-2 PCR or antibody test * age ≥ 16years * resident in Tyrol (Austria)

Design outcomes

Primary

Measure	Time frame	Description
Population based data on spectrum and recovery from COVID-19 symptoms	two weeks after infection	Percentage of patients manifesting ongoing symptoms after 2 weeks of infection.
Predictors of recovery.	up to 24 weeks	Identification of symptoms or comorbidities associated with Long-Covid-19.

Countries

Austria

Contacts

Primary ContactJudith Löffler-Ragg, MD

judith.loeffler@i-med.ac.at++43-512-504-81413

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026